Insulin-Resistant Diabetes Mellitus with Acanthosis Nigricans

Also Known As:

Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans; Diabetes Mellitus, Insulin-Resistant, with Acanthosis Nigricans, Type A; IRAN, Type A; Insulin Receptor Defect with Insulin-Resistant Diabetes Mellitus and Acanthosis Nigricans

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1.	Donohue Syndrome

Experts

1.	Hijikata, Atsushi: 1 article (12/2017)
2.	Kashimada, Kenichi: 1 article (12/2017)
3.	Miyakawa, Yuichi: 1 article (12/2017)
4.	Morio, Tomohiro: 1 article (12/2017)
5.	Nomura, Risa: 1 article (12/2017)
6.	Numakura, Chikahiko: 1 article (12/2017)
7.	Ogawa, Yoshihiro: 1 article (12/2017)
8.	Shirai, Tsuyoshi: 1 article (12/2017)
9.	Takasawa, Kei: 1 article (12/2017)
10.	Tsuji-Hosokawa, Atsumi: 1 article (12/2017)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Insulin-Resistant Diabetes Mellitus with Acanthosis Nigricans:

1.	Messenger RNA (mRNA)IBA 12/01/2017 - "We detected 2 missense mutations in 2 cases of leprechaunism and IRAN, type A, and reduced mRNA expression in the leprechaunism case. "